Search

everythinglearnresearchcommunity

for

Search:↓

Different skin conditions show distinct types of vessel inflammation, a new quality of life index for vulval disease is reliable, a certain intrauterine system might be linked to chronic vaginal yeast infections, and oral minoxidil reduces hair loss in women.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

A woman got unwanted hair growth on her face from using bimatoprost eyedrops for glaucoma.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Melanocyte precursors in human fetal skin follow a specific migration pattern and some remain in the skin's deeper layers.

Human skin can make serotonin and melatonin, which help protect and maintain it.

Skin problems are very common in people with end-stage kidney disease.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

The study found that a specific signaling pathway helps skin wounds heal faster but may lead to larger scars.

Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.

Primary health care in Florianópolis mostly treated simple skin conditions, while secondary care handled more complex skin diseases.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

Skin and hair renewal is maintained by both fast and slow cycling stem cells, with hair regrowth primarily driven by specific stem cells in the hair follicle bulge. These cells can also help heal wounds and potentially treat hair loss.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Targeted cancer therapies often cause serious skin problems that need careful management.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Some patients taking antipsychotic medications experience skin reactions, ranging from mild to severe.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Researchers found a safe and effective way to pick genetically modified skin cells with high growth potential using CD24.

KLF4 is important for maintaining skin stem cells and helps heal wounds.